Medical Archives - PR FIRE US

Calitii, a Synechron company, secures Managed Services contract with BridgeBio to drive ServiceNow operational excellence

LONDON, UK. January 19th 2026 – Calitii, a Synechron company and global IT consultancy, today announced it has secured a contract with BridgeBio, a biopharmaceutical company, to provide comprehensive ServiceNow Managed Services. The partnership builds on the greenfield ServiceNow IT Service Management implementation Calitii carried out last year to the

January 21, 2026

With Dry January Now a Cultural Fixture, Mountainside Expert Jana Wu Urges Medical Safety, Family Support

FOR IMMEDIATE RELEASE: Wednesday, January 14, 2026Griffin Gonzales, Mountainside: (231) 794-9450, griffin.gonzales@mountainside.com Mountainside addiction treatment expert Jana Wu, LCSW, spoke on a sold-out WBUR panel in Boston about the rise of Dry January and the “sober curious” movement. Wu emphasized the medical risks of quitting alcohol abruptly, the importance of

January 15, 2026

BridgeHead Software Appoints Tony Fossile as Senior Director of Sales, North America

Bringing further clinical and Enterprise Imaging expertise to the BridgeHead team as the company continues to expand its footprint of its Clinical Data Repository, HealthStore® WOBURN, US and LEATHERHEAD, UK – 28th November 2025 – BridgeHead Software, the healthcare data management company, is delighted to announce the appointment of

November 28, 2025

Smart Reporting Set to Acquire Fluency for Imaging to create Jacobian

PITTSBURGH, PA. October 23rd, 2025 – Smart Reporting, a pioneer in AI-powered diagnostic reporting, has entered into a definitive agreement to acquire Fluency for Imaging (FFI), the market-leading radiology reporting and workflow platform. Founded by radiologists in 2014, Smart Reporting has become a global reference point for standardized and automated

October 23, 2025

Mountainside The Leader in Kratom Treatment Reports A Surge in Kratom Detox Admissions Amid Growing National Concern

CANAAN, CT. October 14th 2025 — Mountainside Treatment Center’s Detox Program is experiencing a notable rise in kratom-related admissions as lawmakers and public health officials nationwide intensify scrutiny of the unregulated substance and its potent derivative, 7-hydroxymitragynine (7-OH). Following Florida’s statewide ban on 7-OH and pending Connecticut legislation (HB

October 14, 2025

SciSure and My Green Lab Unite to Champion Safety and Sustainability in Science

SciSure and My Green Lab Unite to Champion Safety and Sustainability in Science Boston, US. September 24th 2025 – In a joint commitment to safe, reproducible, and environmentally responsible science, SciSure and My Green Lab® today announced a strategic partnership aimed at transforming lab operations. By combining SciSure’s integrated scientific

September 25, 2025

Upperton win Pharma Contract Services Company of the Year at the Pharma Industry Awards UK 2025

Nottingham, UK. September 15th 2025 – Upperton Pharma Solutions has added another impressive award to a growing list of achievements, winning the award for Pharma Contract Services Company of the Year at the Pharma Industry Awards UK 2025 and being nominated as a finalist for Pharma Company of the Year.

September 15, 2025

SciSure Acquires Labfolder and Labregister from Labforward

Berlin, Germany. September 11th, 2025 – SciSure today announced the acquisition of Labfolder and Labregister, two flagship products from Labforward, reinforcing its mission to become the home base for connected and reproducible science. The addition of Labfolder, a leading electronic lab notebook (ELN), and Labregister, a widely adopted inventory management

September 11, 2025

Upperton Pharma Solutions Advancing Oral Vaccines Delivery with Oxford’s Pandemic Sciences Institute

Nottingham, UK. August 14th 2025 – Upperton Pharma Solutions, a leading UK-based contract development and manufacturing organisation (CDMO), has been awarded a grant as part of the first VaxHub Sustainable Platform Funding Call, in collaboration with the University of Oxford. The funding supports the development of an oral formulation for

August 18, 2025

Medical Newsroom